Navigate the Complexities of Life Sciences Commercialization and Health Policy

Don’t just react to a changing market, lead it. ADVI provides a clear, data-driven foundation that connects government policy, clinical proof, and patient access to ensure your innovation reaches its full potential.

Marc Samuels, JD, MPH

Chief Executive Officer

At ADVI, we don’t just monitor the shifting landscape of healthcare policy—we help our clients navigate it. Whether it is modeling the impact of the Inflation Reduction Act or securing market access for a breakthrough therapy, our mission is to turn regulatory complexity into a clear, actionable path toward commercial success and patient impact. We help them obtain codes, secure reimbursement, and gain or enhance coverage.

In an era of shifting mandates, certainty is your greatest asset.

Most consulting firms are reactive, you call them only when a crisis hits. We work differently. As your long-term strategic partner, we provide the foresight to navigate obstacles before they appear. We anticipate how today’s news shapes tomorrow’s policies, translating complex data into the actionable insights you need to make confident decisions through implementation and beyond.

Solutions and Services

Market Access and Commercialization

Specializing in cell and gene therapy commercialization and pharmaceutical market access consulting. We ensure your product’s value is recognized by payers and providers alike.

Reimbursement Strategy

As a leading reimbursement consultant firm, we help you navigate coding, coverage, and payment complexities.

Policy and Government Affairs

Direct insights from health policy consultants. We provide government healthcare consulting to help you stay ahead of federal and state legislative shifts.

Data and Analytics

Leverage market access analytics and health economics consultancy to build a data-backed narrative for your therapy or device.

Specialized Expertise

Leading the Way in Cell and Gene Therapy Access Models

Cell and Gene therapies require more than traditional strategies. We act as your health economics consulting firm, developing innovative payment models and long-term market access support for high-cost, high-impact curative therapies.

Is Your Portfolio Ready for the Inflation Reduction Act (IRA)?

Our consultants, specializing in the Inflation Reduction Act and Most Favored Nation, provide rigorous impact modeling and strategic advisory to mitigate risk and protect innovation value.

Where Policy Meets Patient Impact

ADVI is among the premier healthcare advisory firms, offering influential solutions informed by data. Our team bridges the gap between complex science and commercial reality.